Who makes PP405 0.05% Topical Gel?

PP405 0.05% Topical Gel is developed by Pelage Pharmaceuticals, Inc..

What development phase is PP405 0.05% Topical Gel in?

PP405 0.05% Topical Gel is in Phase 2.

Last reviewed 2026-04-19 · How we verify

PP405 0.05% Topical Gel

Pelage Pharmaceuticals, Inc. · Phase 2 active Small molecule

At a glance

Generic name	PP405 0.05% Topical Gel
Sponsor	Pelage Pharmaceuticals, Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PP405 0.05% Topical Gel CI brief — competitive landscape report
PP405 0.05% Topical Gel updates RSS · CI watch RSS
Pelage Pharmaceuticals, Inc. portfolio CI